Dr Reddys Laboratories RDY
NYSE RDY
$11.88 +0.00 (+0.00%)
As of: Sep 9, 2026 · 3:59 PM EDT

Dr Reddys Laboratories (RDY) Goodwill & Intangibles (2009 - 2026)

Dr Reddys Laboratories (RDY) posted Goodwill & Intangibles of $1.2 billion for Q2 2026, down 4.66% on a QoQ basis from $1.3 billion in Q1 2026, and down 2.13% year-over-year from $1.3 billion in Q2 2025.

Analysis

Dr Reddys Laboratories (RDY) Goodwill & Intangibles (2009 - 2026) Analysis & Trends

Dr Reddys Laboratories has reported Goodwill & Intangibles for 18 years, with the latest figure at $1.2 billion in Q2 2026.

  • On a quarterly basis, Goodwill & Intangibles fell 2.13% year-over-year to $1.2 billion in Q2 2026; TTM through Jun 2026 was $1.2 billion, a 2.13% decrease from a year earlier, with the FY2026 full-year figure at $1.3 billion, up 5.06% from the prior year.
  • Goodwill & Intangibles was $1.2 billion for Q2 2026 at Dr Reddys Laboratories, down from $1.3 billion in the prior quarter.
  • The five-year high for Goodwill & Intangibles was $1.3 billion in Q3 2025, with the low at $421.1 million in Q1 2022.
  • Average Goodwill & Intangibles over 5 years is $822.3 million, with a median of $507.1 million recorded in 2023.
  • The sharpest annual moves came in 2022 and 2025: Goodwill & Intangibles declined 23.65% in 2022, then soared 153.43% in 2025.
  • Over 5 years, Goodwill & Intangibles stood at $431.2 million in 2022, then climbed by 14.73% to $494.7 million in 2023, then jumped by 150.85% to $1.2 billion in 2024, then climbed by 3.81% to $1.3 billion in 2025, then slipped by 4.51% to $1.2 billion in 2026.
  • The last three Goodwill & Intangibles figures came in at $1.2 billion (Q2 2026), $1.3 billion (Q1 2026), and $1.3 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn
10 RedHill Biopharma 178.35 Mn 178.35 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.23 Bn
Mar 31, 2026 1.29 Bn
Dec 31, 2025 1.29 Bn
Sep 30, 2025 1.30 Bn
Jun 30, 2025 1.26 Bn
Mar 31, 2025 1.25 Bn
Dec 31, 2024 1.24 Bn
Sep 30, 2024 1.24 Bn
Jun 30, 2024 495.98 Mn
Mar 31, 2024 496.16 Mn
Dec 31, 2023 494.71 Mn
Sep 30, 2023 499.34 Mn
Jun 30, 2023 514.93 Mn
Mar 31, 2023 426.91 Mn
Dec 31, 2022 431.18 Mn
Sep 30, 2022 452.59 Mn
Jun 30, 2022 469.63 Mn
Mar 31, 2022 421.10 Mn
Dec 31, 2021 488.23 Mn
Sep 30, 2021 502.14 Mn